glp-1 approval GLP-1s What's next for GLP-1 innovation:

Sources: Why Do They Happen

The functions are illustrated in the Figure ( Figure 4 )

In addition to the hormones GIP and glucagon, other hormones such as estrogen, peptide tyrosine tyrosine (PYY), gastrin, xenin, and fibroblast growth factor 21 can be good candidates to pair with GLP-1 and create dual agonists that have anti-diabetic and anti-obesity effects

Without professional oversight, patients risk side effects, poor results, or wasted money

From there, your provider may increase the dose in 2.5 mg increments every four weeks until reaching a maintenance dose between 5 mg and 15 mg weekly

Zepbound and Semaglutide are both GLP-1 medications for weight loss and diabetes management, but they differ in their mechanisms and effectiveness